Target intelligence / Profile preview

Immune effector cell activity

Molecular classification
Other
01

Overview

"Immune effector cell activity" refers to the collective functions of immune cells (most notably T lymphocytes, NK cells, and some subclasses of B cells and myeloid cells) that mediate the active elimination of infected, malignant, or otherwise abnormal cells. Effector functions include direct cytotoxicity (cell killing), secretion of cytokines that orchestrate broader immune responses, and engagement in antibody-dependent mechanisms such as ADCC. These activities are central to host defense against pathogens and tumors but can also contribute to immunopathology in autoimmunity and therapy-related toxicities

Other names
Immune cell activityEffector cell functionEffector function
02

Mechanism of action

Modulation (activation or inhibition) of immune effector cells (e.g., T cells, NK cells); Antibody-dependent cellular cytotoxicity (ADCC); Antibody-dependent cellular phagocytosis; Release of cytotoxic molecules and cytokines

03

Biological functions

Immune responseCytotoxicityCytokine productionAntibody-dependent cell-mediated cytotoxicity (ADCC)Cell-mediated immunity
04

Disease associations

CancerInfectionInflammationAutoimmune diseaseOther (broadly implicated in immune-mediated diseases)
05

Safety considerations

Cytokine release syndromeOff-target cytotoxicityImmune-related adverse events (e.g. autoimmune toxicity from T-cell activation)On-target, off-tumor effects in cancer therapies (CAR T or bispecific antibodies)
06

Interacting drugs

Immune checkpoint inhibitors (e.g., pembrolizumab, nivolumab)

2 more in the full profile.

07

Biomarkers

Granzyme Bperforininterferon-γ (for cytotoxic T and NK cells)CD69CD107a (early activation/effector markers)Fc receptor expression (for antibody-mediated functions)

Beyond the preview

Go deeper on Immune effector cell activity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune effector cell activity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call